1
|
Zhang Y, Lv Z, Peng P, Zhao T. Association between red blood cell distribution width and psoriasis among the US adults. Front Med (Lausanne) 2023; 10:1290514. [PMID: 38179271 PMCID: PMC10764517 DOI: 10.3389/fmed.2023.1290514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2023] [Accepted: 12/11/2023] [Indexed: 01/06/2024] Open
Abstract
Introduction The association between red blood cell distribution width (RDW) and psoriasis among the US adults is still unknown. We aimed to assess whether RDW is associated with psoriasis in the US adults. Method We conducted a cross-sectional study consisting of 14,089 participants from National Health and Nutrition Examination Survey (NHANES) 2009-2014. Psoriasis status were assessed by self-reported questionnaire. We evaluated the association between RDW and risk of psoriasis using multivariate regression models. Subgroup and interaction analysis were performed. Results The higher RDW level was associated with an increased risk of psoriasis (OR = 1.10 [95% CI, 1.01, 1.19]; p = 0.025) after adjusting for confounders in female. However, there is no significant association between RDW and risk of psoriasis among male (OR = 0.99 [95% CI, 0.87, 1.15]; p = 0.992). Subgroup and interaction analysis found that the strongest positive association mainly exists in female participants with BMD greater than 29.9 kg/m2 (OR = 1.20 [95% CI, 1.09, 1.32], Pint = 0.004). Discussion In conclusion, we found that increased RDW levels were associated with an increased risk of psoriasis in females, which could provide clinicians with auxiliary data for the early diagnosis of psoriasis.
Collapse
Affiliation(s)
- Yunqi Zhang
- Department of Pharmacy, Guangzhou Institute of Dermatology, Guangzhou, China
| | - Zheng Lv
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Peng Peng
- The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China
| | - Tie Zhao
- Department of Pharmacy, Guangzhou Institute of Dermatology, Guangzhou, China
| |
Collapse
|
2
|
Zhai R, Chen X, Wang G, Xu J, Yang Y. Predictive Value of Red Cell Distribution Width in the Diagnosis of Peripherally Inserted Central Catheter (PICC)-Related Thrombosis Among Cancer Patients. Int J Gen Med 2023; 16:359-365. [PMID: 36747971 PMCID: PMC9899010 DOI: 10.2147/ijgm.s395745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 01/17/2023] [Indexed: 02/03/2023] Open
Abstract
Purpose This study aimed to investigate the predictive value of red cell distribution width (RDW) in patients with peripherally inserted central catheter (PICC)-related thrombosis. Patients and methods This was a case‒control study. A total of 98 cancer patients undergoing PICC placement from January 2017 to December 2019 at the ICU Venous Access Center of Peking University Cancer Hospital were retrospectively analyzed. These included 47 cases in the thrombosis group and 51 cases in the nonthrombosis group according to the occurrence of PICC-related thrombosis within 90 days after the PICC procedure. Results a) RDW was significantly higher in the thrombosis group (15.98±1.93) than in the nonthrombosis group (13.98±1.09). Additionally, the number of smoking histories in the thrombosis group (18, 38.30%) was significantly higher than that in the nonthrombosis group (5, 9.80%). b) Logistic regression analysis indicated that RDW and smoking history were independent risk factors for PICC-related thrombosis (OR: 3.028, P<0.001; OR: 5.640, P=0.023). c) The area under the receiver operating characteristic (ROC) curve of the combination of RDW and smoking history was 86.8%, and the sensitivity and specificity for predicting thrombosis after PICC were 85.1% and 80%, respectively. d) Cox regression analysis revealed that RDW and smoking history were independent risk factors for PICC-related thrombosis (p<0.001). e) Results from Kaplan‒Meier analysis showed that incidence of PICC-related thrombosis in patients with RDW less than 14.75% is significantly lower than those with RDW 14.75% and above (p<0.001). e) Baseline RDW was not different between the two groups (P>0.05), ΔRDW was significantly different between the two groups (p<0.001). Conclusion The combined use of RDW and smoking history has early evaluation and predictive value in the diagnosis of PICC-related thrombosis.
Collapse
Affiliation(s)
- Rui Zhai
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Critical Care Medicine, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China
| | - Xiaojie Chen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Critical Care Medicine, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China
| | - Guodong Wang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Critical Care Medicine, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China
| | - Jiaxuan Xu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Critical Care Medicine, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China
| | - Yong Yang
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Critical Care Medicine, Peking University Cancer Hospital & Institute, Beijing, People’s Republic of China,Correspondence: Yong Yang, Peking University Cancer Hospital & Institute, No. 52 of Fucheng Road, Haidian District, Beijing, 100142, People’s Republic of China, Tel +86-10-88197798, Email
| |
Collapse
|
3
|
Yin JM, Zhu KP, Guo ZW, Yi W, He Y, Du GC. Is red cell distribution width a prognostic factor in patients with breast cancer? A meta-analysis. Front Surg 2023; 10:1000522. [PMID: 37035565 PMCID: PMC10079877 DOI: 10.3389/fsurg.2023.1000522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2022] [Accepted: 02/14/2023] [Indexed: 04/11/2023] Open
Abstract
Purpose The current study aimed to investigate whether red blood cell distribution width (RDW) can predict the prognosis of patients with breast cancer (BC). Methods We searched four databases, including PubMed, Embase, Cochrane Library databases, and CNKI, from inception to Jun 13, 2022. The primary outcome was overall survival (OS), and the secondary outcome was disease-free survival (DFS). A subgroup analysis was conducted based on different treatments. This meta-analysis was performed with RevMan 5.3 (The Cochrane Collaboration, London, United Kingdom). Results A total of seven studies including 4,884 BC patients were identified. The high RDW group had a larger tumor size (OR = 2.12, 95% CI = 1.67 to 2.68, P < 0.01), higher proportions of advanced stage tumors (OR = 1.77, 95% CI = 1.38 to 2.27, P < 0.01), more lymph node metastases (OR = 2.00, 95% CI = 1.58 to 2.51, P < 0.01) and lower HER-2 expression (OR = 0.76, 95% CI = 0.61 to 0.95, P = 0.02). For prognosis, after pooling all the data, we found that the high RDW group was associated with worse OS (HR = 2.12, 95% CI = 1.47 to 3.08, P < 0.01) and DFS (HR = 1.77, 95% CI = 1.32 to 2.37, P < 0.01). The subgroup analysis found that RDW had prognostic significance but only for surgery-only patients (HR = 2.41, 95% CI = 1.67 to 3.49, P < 0.01). Conclusion High RDW was associated with worse OS and DFS. Therefore, RDW was a simple predictive factor for the prognosis of BC patients.
Collapse
|
4
|
Kim M, Lee CJ, Kang H, Son N, Bae S, Seo J, Oh J, Rim S, Jung IH, Choi E, Kang S. Red cell distribution width as a prognosticator in patients with heart failure. ESC Heart Fail 2022; 10:834-845. [PMID: 36460487 PMCID: PMC10053156 DOI: 10.1002/ehf2.14231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 10/28/2022] [Accepted: 11/04/2022] [Indexed: 12/04/2022] Open
Abstract
AIMS Increased red cell distribution width (RDW) is a poor prognostic factor in patients with heart failure (HF). However, only a few large-scale studies have identified the clinical utility of RDW after adjusting for covariates affecting RDW. METHODS AND RESULTS From January 2010 to April 2021, we retrospectively enrolled patients diagnosed with HF from three referral hospitals with available RDW data (taken within 3 months of HF diagnosis) using an integrated clinical data system. Patients with an ejection fraction (EF) < 50% or HFA-PEFF (Heart Failure Association Pre-test assessment, Echocardiography and natriuretic peptide, Functional testing, Final aetiology) score ≥ 2 without severe valvular heart disease or coronary revascularization were enrolled. The primary endpoint was all-cause mortality, and cardiovascular mortality was also collected. Multivariable Cox regression analysis and stabilized inverse probability of treatment weighting (IPTW) were used to identify any association between RDW and all-cause death by balancing covariates or compounding factors. The global χ2 score was calculated and discrimination analysis was performed to evaluate the incremental value of RDW in predicting prognosis. Among the 6599 participants enrolled in this study, 1256 (19.0%) cases of all-cause death occurred, and the median duration of follow-up was 887 (interquartile range 351-1589) days. Elevated RDW at the initial diagnosis was associated with poor prognosis [cumulative incidence: 819 (30.2%) vs. 437 (11.2%), relative risk 1.58, 95% confidence interval (CI) 1.51-1.67, log-rank P < 0.001]. Multivariable Cox analysis showed that elevated RDW was a poor prognostic factor for the primary endpoint [hazard ratio (HR) 1.11, 95% CI 1.06-1.16, P < 0.001], independent of clinical risk factors, N-terminal pro-brain natriuretic peptide (NT-proBNP), and EF, which was concordant with the stabilized IPTW (HR 1.29, 95% CI 1.10-1.49, P < 0.001). Adding RDW to model composed of traditional risk factors, NT-proBNP, and echocardiographic parameters showed incremental prognostic value for predicting poor prognosis (area under the receiver operating characteristic curve, 0.799-0.826; P < 0.001). CONCLUSIONS Increased RDW at the time of diagnosis is associated with poor prognosis in patients with HF, independent of clinical risk factors, such as NT-proBNP, and echocardiographic parameters. Therefore, RDW may aid in the management of these patients beyond traditional risk factors.
Collapse
Affiliation(s)
- Minkwan Kim
- Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Yongin Severance Hospital Yonsei University College of Medicine 363 Dongbaekjukjeon‐daero, Giheung‐gu Yongin‐si Gyeonggi‐do 16995 Republic of Korea
| | - Chan Joo Lee
- Division of Cardiology, Department of Internal Medicine, Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea
| | - Hye‐Jin Kang
- Department of Internal Medicine, Yongin Severance Hospital Yonsei University College of Medicine Yongin‐si Gyeonggi‐do Republic of Korea
| | - Nak‐Hoon Son
- Department of Statistics Keimyung University Daegu Republic of Korea
| | - SungA Bae
- Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Yongin Severance Hospital Yonsei University College of Medicine 363 Dongbaekjukjeon‐daero, Giheung‐gu Yongin‐si Gyeonggi‐do 16995 Republic of Korea
| | - Jiwon Seo
- Division of Cardiology, Department of Internal Medicine, Heart Center, Gangnam Severance Hospital Yonsei University College of Medicine 211 Eonju‐ro, Gangnam‐gu Seoul 06273 Republic of Korea
| | - Jaewon Oh
- Division of Cardiology, Department of Internal Medicine, Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea
| | - Se‐Joong Rim
- Division of Cardiology, Department of Internal Medicine, Heart Center, Gangnam Severance Hospital Yonsei University College of Medicine 211 Eonju‐ro, Gangnam‐gu Seoul 06273 Republic of Korea
| | - In Hyun Jung
- Division of Cardiology, Department of Internal Medicine, Cardiovascular Center, Yongin Severance Hospital Yonsei University College of Medicine 363 Dongbaekjukjeon‐daero, Giheung‐gu Yongin‐si Gyeonggi‐do 16995 Republic of Korea
| | - Eui‐Young Choi
- Division of Cardiology, Department of Internal Medicine, Heart Center, Gangnam Severance Hospital Yonsei University College of Medicine 211 Eonju‐ro, Gangnam‐gu Seoul 06273 Republic of Korea
| | - Seok‐Min Kang
- Division of Cardiology, Department of Internal Medicine, Severance Hospital Yonsei University College of Medicine Seoul Republic of Korea
| |
Collapse
|
5
|
Fan HX, Xiao ZW. Predictors of rebleeding in patients with acute non-variceal upper gastrointestinal bleeding. Shijie Huaren Xiaohua Zazhi 2022; 30:280-286. [DOI: 10.11569/wcjd.v30.i6.280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND There is a risk of rebleeding after acute non-variceal upper gastrointestinal bleeding (ANVUGIB), and rebleeding increases the risk of poor prognosis. At present, there is no effective predictive method for such rebleeding. The changes of red blood cell distribution width as well as hemoglobin and gastrin levels are all related to bleeding diseases, which can provide a reference for clinical improvement of relevant mechanisms and prediction of bleeding.
AIM To investigate the relationship of the red blood cell distribution width (RDW), hemoglobin (Hb), and gastrin (GAS) with Glasgow-Blatchford score (GBS) and AIMS65 score in patients with ANVUGIB and to explore their predictive value for rebleeding.
METHODS A prospective cohort study was conducted on 122 ANVUGIB patients admitted to our hospital from August 2018 to February 2021, and they were divided into either a rebleeding group (n = 31) or a no-rebleeding group (n = 91) according to whether rebleeding occurred 7 d after onset. Baseline data, RDW, Hb, GAS, GBS score, and AIMS65 score were compared between the two groups. Pearson correlation analysis was performed to explore the relationship of each index with GBS and AIMS65 scores, and multi-factor logistic regression analysis was performed to identify the influencing factors of rebleeding. The receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to analyze the value of each index in predicting rebleeding, and to compare the incidence of rebleeding in patients with different levels of each index.
RESULTS The proportion of patients with gastrointestinal bleeding in the rebleeding group was higher than that of the no-rebleeding group. The RDW, GAS, and GBS and AIMS65 scores were higher and Hb was lower in the rebleeding group than in the no-rebleeding group (P < 0.05). RDW and GAS were positively correlated with GBS and AIMS65 scores, and Hb was negatively correlated with GBS and AIMS65 scores (P < 0.05). Multivariate logistic regression analysis showed that after controlling for past gastrointestinal bleeding, GBS, and AIMS65 score, RDW, Hb, and GAS were still influencing factors of rebleeding (P < 0.05). The performance of RDW and Hb combined with GAS for predicting rebleeding (AUC = 0.850) was better than that of RDW (0.721), Hb (0.721), or GAS (0.806) alone. The rebleeding rate in patients with high levels of RDW and GAS was higher than that of patients with low levels, but patients with high levels of Hb had a lower rebleeding rate than those with low levels (P < 0.05).
CONCLUSION RDW, Hb, and GAS are related to the risk of disease and rebleeding in patients with ANVUGIB. Combined detection of them may be a reliable method to assess the risk of disease and predict rebleeding.
Collapse
Affiliation(s)
- Hong-Xing Fan
- Emergency Department, Tongxiang First People's Hospital, Tongxiang 314500, Zhejiang Province, China
| | - Zheng-Wu Xiao
- Emergency Department, Tongxiang First People's Hospital, Tongxiang 314500, Zhejiang Province, China
| |
Collapse
|
6
|
Günaydın O, Günaydın EB. Evaluation of hematological parameters related to systemic inflammation in acute and subacute/chronic low back pain. Biomark Med 2021; 16:31-40. [PMID: 34856812 DOI: 10.2217/bmm-2021-0431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aim: To compare the hematological parameters associated with systemic inflammation between acute and subacute/chronic nonspecific low back pain and to evaluate their diagnostic roles in relation to chronicity in low back pain. Materials & methods: This retrospective case-control study included 150 participants aged 18-65 years with acute nonspecific low back pain, 150 with subacute/chronic nonspecific low back pain, 150 as the control group. Results: Red cell distribution width was significantly higher in the subacute/chronic pain group compared with the acute pain group (p = 0.003), and had a poor diagnostic value for chronicity (cutoff: 11.95, p = 0.003). There were no significant differences in terms of other parameters (p > 0.05). Conclusion: Red cell distribution width has a poor diagnostic value for chronicity in nonspecific low back pain.
Collapse
Affiliation(s)
- Okan Günaydın
- Emergency Service, Ankara Yıldırım Beyazıt University, Yenimahalle Training & Research Hospital, Ankara, 38000, Turkey
| | - Elzem Bolkan Günaydın
- Department of Physical Medicine & Rehabilitation, Faculty of Medicine, Ufuk University, Ankara, 38000, Turkey
| |
Collapse
|
7
|
Yang P, Li H, Zhang J, Xu X. Research progress on biomarkers of pulmonary embolism. Clin Respir J 2021; 15:1046-1055. [PMID: 34214256 DOI: 10.1111/crj.13414] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 06/16/2021] [Accepted: 06/29/2021] [Indexed: 01/05/2023]
Abstract
OBJECTIVES To present a review on the traditional and new biomarkers of pulmonary embolism (PE). DATA SOURCE A systematic search has been carried out using keywords as PE, biomarker, diagnosis and risk stratification. RESULTS The results of this work have been structured into three parts: first, conventional biomarkers for vascular, cardiac and inflammation, including static markers and dynamic markers for measuring the time course; next, a review of new biomarkers in recent years, such as RNAs and markers obtained through proteomics and mass spectrometry; finally, use of new detection methods to directly detect the activity of existing markers, such as the determination of coagulation factor II and plasmin activities based on the proteolytic activation of an engineered zymogen. CONCLUSIONS This work summarized the characteristics of current traditional biomarkers for clinical diagnosis and risk stratification of PE, as well as a series of newly discovered biomarkers obtained through various clinical experimental methods.
Collapse
Affiliation(s)
- Pengbo Yang
- Department of Laboratory Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
| | - Hexin Li
- Clinical Biobank, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
| | - Junhua Zhang
- The Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
| | - Xiaomao Xu
- Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, China
| |
Collapse
|